ロード中...
Investigational drugs for the treatment of AD: what can we learn from negative trials?
Given the level of interest and activity in the race to find a treatment for Alzheimer's disease, it is expected that a reasonably safe and effective drug will be identified within the next decade. It may be worthwhile to pause periodically during the course of this race to take stock of what w...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3226276/ https://ncbi.nlm.nih.gov/pubmed/21539725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt73 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|